Abstract
A brain arteriovenous malformation (BAVM) is a neurovascular entity that consists of a localized dense network of abnormal blood vessels (a nidus) that hold arteries shunting directly into veins in the absence of a capillary bed. In their natural history, BAVMs carry a risk of hemorrhage or other neurological complications, for which reason they are frequently treated. Cerebral proliferative angiopathy (CPA) is a different type of neurovascular malformation with distinct angiographic and clinical features that can be used to differentiate it from a classical BAVM. The basic difference between CPA and a BAVM is that CPA has normal brain tissue intermingled in-between its network of vessels. Treatment of CPA by surgery, radiosurgery, or embolization consequently harbors a high risk of neurological complications. As such, reliable diagnostic discrimination between CPA and BAVM is crucial to adequately treat patients. However, despite the fact that CPA has some characteristic imaging features, the differentiation between CPA and a brain AVM may be difficult. PET imaging as a technique that reveals functional brain tissue is therefore likely to be of additional diagnostic value.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Shahi R, Warlow C (2001) A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 124:1900–1926
Anderson FM, Korbin MA (1958) Arteriovenous anomalies of the brain; a review and presentation of 37 cases. Neurology 8:89–101
Beer AJ, Kessler H, Wester H-J, Schwaiger M (2011) PET imaging of integrin αVβ3 expression. Theranostics 1:48–57
Brown RD, Wiebers DO, Forbes G et al (1988) The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 68:352–357. https://doi.org/10.3171/jns.1988.68.3.0352
Chen Y, Zhu W, Bollen AW et al (2008) Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery 62:1340–1349; discussion 1349–1350. https://doi.org/10.1227/01.neu.0000333306.64683.b5
Chin LS, Raffel C, Gonzalez-Gomez I et al (1992) Diffuse arteriovenous malformations: a clinical, radiological, and pathological description. Neurosurgery 31:863–868; discussion 868–869
Crawford PM, West CR, Chadwick DW, Shaw MD (1986) Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 49:1–10
da Costa L, Wallace MC, ter Brugge KG et al (2009) The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 40:100–105. https://doi.org/10.1161/STROKEAHA.108.524678
De Reuck J, Van Aken J, Van Landegem W, Vakaet A (1989) Positron emission tomography studies of changes in cerebral blood flow and oxygen metabolism in arteriovenous malformation of the brain. Eur Neurol 29:294–297
Doorduin J, de Vries EFJ, Dierckx RA, Klein HC (2008) PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr Pharm Des 14:3297–3315
Ducreux D, Petit-Lacour MC, Marsot-Dupuch K et al (2002a) Functional MRI in symptomatic proliferative angiopathies. Neuroradiology 44:883–892. https://doi.org/10.1007/s00234-002-0871-2
Ducreux D, Petit-Lacour MC, Marsot-Dupuch K et al (2002b) MR perfusion imaging in a case of cerebral proliferative angiopathy. Eur Radiol 12:2717–2722. https://doi.org/10.1007/s00330-001-1293-y
Ducreux DD, Meder JFJ, Fredy DD et al (2004) MR perfusion imaging in proliferative angiopathy. Neuroradiology 46:105–112. https://doi.org/10.1007/s00234-003-1045-6
Ellis MJ, Armstrong D, Dirks PB (2011) Large vascular malformation in a child presenting with vascular steal phenomenon managed with pial synangiosis. J Neurosurg Pediatr 7:15–21. https://doi.org/10.3171/2010.10.PEDS10388
Fiehler J, Stapf C (2008) ARUBA–beating natural history in unruptured brain AVMs by intervention. Neuroradiology 50:465–467. https://doi.org/10.1007/s00234-008-0380-z
Fierstra J, Conklin J, Krings T et al (2010) Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain 134:100–109. https://doi.org/10.1093/brain/awq286
Fierstra J, Spieth S, Tran L et al (2011) Severely impaired cerebrovascular reserve in patients with cerebral proliferative angiopathy. J Neurosurg Pediatr 8:310–315. https://doi.org/10.3171/2011.6.PEDS1170
Fink GR (1992) Effects of cerebral angiomas on perifocal and remote tissue: a multivariate positron emission tomography study. Stroke 23:1099–1105
Fleetwood IG, Steinberg GK (2002) Arteriovenous malformations. Lancet 359:863–873. https://doi.org/10.1016/S0140-6736(02)07946-1
Fullerton HJ, Achrol AS, Johnston SC et al (2005) Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 36:2099–2104. https://doi.org/10.1161/01.STR.0000181746.77149.2b
Golestani R, Zeebregts CJ, Terwisscha van Scheltinga AG et al (2013) Feasibility of VEGF imaging in human atherosclerotic plaque using 89Zr-bevacizumab positron emission tomography. Mol Imaging 12(4):235–243
Graf CJ, Perret GE, Torner JC (1983) Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58:331–337. https://doi.org/10.3171/jns.1983.58.3.0331
Iwama T, Hayashida K, Takahashi JC et al (2002) Cerebral hemodynamics and metabolism in patients with cerebral arteriovenous malformations: an evaluation using positron emission tomography scanning. J Neurosurg 97:1314–1321. https://doi.org/10.3171/jns.2002.97.6.1314
Kaminaga T, Hayashida K, Iwama T, Nishimura T (1999) Hemodynamic changes around cerebral arteriovenous malformation before and after embolization measured with PET. J Neuroradiol 26:236–241
Kuroda S, Furukawa K, Shiga T et al (2004) Pretreatment and posttreatment evaluation of hemodynamic and metabolic parameters in intracranial dural arteriovenous fistulae with cortical venous reflux. Neurosurgery 54:585–591; discussion 591–2
Lasjaunias PL, Landrieu P, Rodesch G et al (2008) Cerebral proliferative angiopathy: clinical and angiographic description of an entity different from cerebral AVMs. Stroke 39:878–885. https://doi.org/10.1161/STROKEAHA.107.493080
Mast H, Mohr JP, Osipov A et al (1995) “Steal” is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke 26:1215–1220
Meisel HJ, Mansmann U, Alvarez H et al (2002) Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir 144:879–887; , discussion 888. https://doi.org/10.1007/s00701-002-0978-6
Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422
Nagengast WB, de Vries EG, Hospers GA et al (2007) In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med 48:1313–1319. https://doi.org/10.2967/jnumed.107.041301
Nagengast WB, de Korte MA, Oude Munnink TH et al (2010) 89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922. J Nucl Med 51:761–767. https://doi.org/10.2967/jnumed.109.071043
Nagengast WB, Hooge MNL-D, van Straten EME et al (2011) VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patients. Eur J Cancer 47:1595–1602. https://doi.org/10.1016/j.ejca.2011.02.009
Ogilvy CS, Stieg PE, Awad I et al (2001) AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Stroke Association. Stroke 32:1458–1471
Ondra SL, Troupp H, George ED, Schwab K (1990) The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 73:387–391. https://doi.org/10.3171/jns.1990.73.3.0387
Sollevi A, Ericson K, Eriksson L et al (1987) Effect of adenosine on human cerebral blood flow as determined by positron emission tomography. J Cereb Blood Flow Metab 7:673–678. https://doi.org/10.1038/jcbfm.1987.121
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483. https://doi.org/10.3171/jns.1986.65.4.0476
Stapf C, Mast H, Sciacca RR et al (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66:1350–1355. https://doi.org/10.1212/01.wnl.0000210524.68507.87
Tyler JL, Leblanc R, Meyer E et al (1989) Hemodynamic and metabolic effects of cerebral arteriovenous malformations studied by positron emission tomography. Stroke 20:890–898
Vargas MC, Castillo M (2011) Magnetic resonance perfusion imaging in proliferative cerebral angiopathy. J Comput Assist Tomogr 35:33–38. https://doi.org/10.1097/RCT.0b013e3181ff1e79
Wikholm G, Lundqvist C, Svendsen P (2001) The Göteborg cohort of embolized cerebral arteriovenous malformations: a 6-year follow-up. Neurosurgery 49:799–805; discussion 805–806
Yamamoto YL, Thompson CJ, Meyer E et al (1977) Dynamic positron emission tomography for study of cerebral hemodynamics in a cross section of the head using positron-emitting 68Ga-EDTA and 77Kr. J Comput Assist Tomogr 1:43–56
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
van Dijk, J.M.C., Krings, T., Doorduin, J., Slart, R.H.J.A. (2021). PET in Brain Arteriovenous Malformations and Cerebral Proliferative Angiopathy. In: Dierckx, R.A.J.O., Otte, A., de Vries, E.F.J., van Waarde, A., Leenders, K.L. (eds) PET and SPECT in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-53168-3_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-53168-3_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53167-6
Online ISBN: 978-3-030-53168-3
eBook Packages: MedicineMedicine (R0)